A Cost Analysis of the 1-2-3 Pap Intervention

Cervical cancer places a substantial economic burden on our healthcare system. The three-dose human papillomavirus (HPV) vaccine series is a cost-effective intervention to prevent HPV infection and resultant cervical cancer. Despite its efficacy, completion rates are low in young women aged 18 throu...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Frontiers in public health services & systems research 2015, Vol.4 (4), p.45-50
Hauptverfasser:	Rabarison, Kristina M, Li, Rui, Bish, Connie L, Vanderpool, Robin C, Crosby, Richard A, Massoudi, Mehran S
Format:	Artikel
Sprache:	eng
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!